Pharmacists in Palm Springs, CA Accepting Medicare
145 Pharmacists found. Showing 141 - 145
 Paula Krause Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1751 N Sunrise Way, Palm Springs, CA 92262 Phone: 760-322-1131 |
Darcy Kranz Tenney, PHARMD, BCACP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 N El Cielo Rd, Palm Springs, CA 92262 Phone: 760-320-8814 |
Arielle Thio, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 N El Cielo Rd Ste C326, Palm Springs, CA 92262 Phone: 760-969-6560 Fax: 760-328-2230 |
Diana Koro Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 174 S Sunrise Way, Palm Springs, CA 92262 Phone: 760-778-8870 |
Bao Chan Nguyen Le, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 N El Cielo Rd Ste C326, Palm Springs, CA 92262 Phone: 760-969-6560 Fax: 760-328-2230 |
News Archive
Study indicates neural pathway that provides pain relief, reduces cravings for opioids
Researchers have discovered that there may be a new pathway in the brain that provides pain relief and reduces cravings for opioids.
Warner Chilcott, sanofi-aventis amend Actonel global collaboration agreement
Warner Chilcott plc and sanofi-aventis announced today an amendment to the Actonel® global collaboration agreement with respect to the parties' arrangement in the United States and Puerto Rico. Under the terms of the amendment, Warner Chilcott will take full operational control over the promotion, marketing and R&D decisions for Actonel in the United States and Puerto Rico, and will assume responsibility for all associated costs relating to those activities.
Disruption of protein folding causes neurodegeneration, mental retardation
Excess accumulation in brain cells of a fat molecule called GM1-ganglioside (GM1) disrupts the folding of newly assembled proteins into their proper shapes, triggering nerve degeneration and mental retardation in children.
Signal Genetics, Caris Life Sciences announce new agreement to commercialize MyPRS tool
Signal Genetics, the parent company of Myeloma Health LLC, a privately held predictive genetic testing company focused on oncology, and Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostic services, today announced a new agreement under which Caris Life Sciences will offer Signal Genetics' new gene expression profile test for Multiple Myeloma to community-based hematologists/medical oncologists nationwide.
Discovery gives clinicians new targets for making existing therapies more effective and developing drugs to inhibit the growth of cancers
A team of researchers at the University of Alberta in Edmonton and the Samuel Lunenfeld Research Institute in Toronto have discovered how a key enzyme involved in repairing DNA is put together and how it works-a development that opens up new therapies for making cancer cells more vulnerable to attack.
› Verified 7 days ago
Pharmacists
Counselors
Marriage Counselors
Clinical Social Workers
Psychologists
Dentists
Occupational Therapists